PROTAGENE

ProtaGene is excited to announce our expanded molecular bioanalytical solutions capacity and capabilities - explicitly tailored for gene therapy developers. Our molecular bioanalytical solutions are designed to enable preclinical assessment of safety risks and monitoring of gene therapies in the clinic... ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms... From research to commercial product release, we provide leading global biopharmaceutical, cell, and gene therapy developers advanced, integrated, and complete analytical solutions and expert consultation to support our global clients' decision-making throughout the development process.

Also known as: ProtaGene CGT GmbH, ProtaGene Group, ProtaGene US, Inc., ProtaGene, GmbH

Registration numbers: HRB 382627 (W)

VAT numbers: DE814132039

Primary location: Heilbronn Germany